Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: AIDS Behav. 2016 Nov;20(11):2654–2661. doi: 10.1007/s10461-016-1312-2

Table 2. Adherence questions used in analysis.

TVB/TOB Question Monthly visits (MBA) Quarterly visits (OPA/VPA)
Q24: How often during the study did you miss or skip days? Q25: When during the study did you start skipping doses? Total number of months per ppt of Q3a: In the past 7 days how many days did you use no product? Total number of months per ppt of Q14a: In the past 7 days how many days did you use no product?
Q32: In a typical month, how would you describe your ability to use the product as instructed? NONE Q13: Please rate your ability, over the past 4 weeks to use the product exactly as you were instructed.
Q33: When you say [category from Q32] in a typical month, on how many days did you not take the tablets/gel? Average per ppt of Q3a: In the past 7 days how many days did you use no product? Average per ppt of Q14a: In the past 7 days how many days did you use no product?
Q34: Did you ever not use the product for 1 week or more in a row? Ever reported no dose for 7 days in Q3a: In the past 7 days how many days did you use no product? Ever reported no dose for 7 days in Q14a: In the past 7 days how many days did you use no product?